H.C. Wainwright Remains a Buy on Amyris Inc (AMRS)

By Jason Carr

H.C. Wainwright analyst Amit Dayal maintained a Buy rating on Amyris Inc (AMRSResearch Report) today and set a price target of $11.00. The company’s shares closed last Monday at $3.46.

According to TipRanks.com, Dayal is a 1-star analyst with an average return of -1.5% and a 40.1% success rate. Dayal covers the Industrial Goods sector, focusing on stocks such as Advanced Emissions Solutions, Inc., Ballard Power Systems, and Capstone Turbine Corp.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Amyris Inc with a $11.00 average price target.

See today’s analyst top recommended stocks >>

The company has a one-year high of $8.43 and a one-year low of $1.87. Currently, Amyris Inc has an average volume of 893.1K.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Amyris, Inc. engages in the provision of bioscience solutions. It offers its products to health and wellness, clean beauty, and flavor and fragrance markets. The company was founded by Jack D. Newman, Kinkead Keith Reiling, and Neil Renninger on July 17, 2003 and is headquartered in Emeryville, CA.